SC
PFE icon

Stralem & Co’s Pfizer PFE Stock Holding History

Stralem & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$4.07M Sell
131,209
-1,486
-1% -$50.5K 2.59% 22
2020
Q1 		$4.11M Sell
132,695
-6,693
-5% -$228K 3.05% 18
2019
Q4 		$5.18M Sell
139,388
-5,397
-4% -$192K 2.9% 18
2019
Q3 		$4.94M Buy
144,785
+1,265
+0.9% +$46K 2.85% 21
2019
Q2 		$5.9M Sell
143,520
-26,213
-15% -$1.04M 3.21% 14
2019
Q1 		$6.84M Buy
169,733
+16,537
+11% +$662K 3.13% 16
2018
Q4 		$6.34M Sell
153,196
-111,105
-42% -$4.61M 3.03% 14
2018
Q3 		$11.1M Sell
264,301
-27,984
-10% -$1.08M 3.28% 7
2018
Q2 		$10.1M Sell
292,285
-175,491
-38% -$6M 2.97% 20
2018
Q1 		$15.8M Sell
467,776
-62,175
-12% -$2.14M 3.13% 15
2017
Q4 		$18.2M Sell
529,951
-76,874
-13% -$2.62M 3.09% 15
2017
Q3 		$20.6M Sell
606,825
-164,909
-21% -$5.3M 2.96% 16
2017
Q2 		$24.6M Buy
771,734
+6,523
+0.9% +$206K 2.88% 24
2017
Q1 		$24.8M Sell
765,211
-15,301
-2% -$482K 2.91% 23
2016
Q4 		$24.1M Sell
780,512
-10,258
-1% -$313K 2.86% 21
2016
Q3 		$25.4M Sell
790,770
-12,121
-2% -$405K 2.95% 17
2016
Q2 		$26.8M Sell
802,891
-84,952
-10% -$2.71M 3.1% 9
2016
Q1 		$25M Sell
887,843
-78,764
-8% -$2.25M 2.73% 22
2015
Q4 		$29.6M Sell
966,607
-312,142
-24% -$9.82M 3% 14
2015
Q3 		$38.1M Sell
1,278,749
-216,702
-14% -$6.95M 3.16% 9
2015
Q2 		$47.6M Sell
1,495,451
-395,018
-21% -$12.9M 3.26% 4
2015
Q1 		$62.4M Sell
1,890,469
-345,455
-15% -$11M 3.48% 1
2014
Q4 		$66.1M Sell
2,235,924
-452,896
-17% -$13M 3.07% 15
2014
Q3 		$75.4M Sell
2,688,820
-676,036
-20% -$19M 3.03% 18
2014
Q2 		$94.8M Sell
3,364,856
-251,342
-7% -$7.16M 3.23% 19
2014
Q1 		$110M Sell
3,616,198
-219,972
-6% -$6.56M 3.48% 14
2013
Q4 		$111M Sell
3,836,170
-358,985
-9% -$10.4M 3.34% 16
2013
Q3 		$114M Sell
4,195,155
-189,328
-4% -$5.15M 3.49% 12
2013
Q2 		$117M Buy
+4,384,483
New +$121M 3.52% 7

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stralem & Co's PFE Position: Q2 2020 in Review

Stralem & Co reduced its Pfizer (PFE) stake by 1.1% in Q2 2020, selling an estimated $50.5K and leaving 131,209 shares worth $4.07M. The position accounts for 2.59% of the portfolio, ranked #22.

Stralem & Co first reported a position in PFE in Q2 2013 and has held it in 29 quarters since. The position peaked at $117M in Q2 2013. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Stralem & Co held 131,209 shares of Pfizer worth $4.07M as of Q2 2020.
  • Stralem & Co sold 1,486 Pfizer shares in Q2 2020, an estimated $50.5K.
  • Pfizer made up 2.59% of Stralem & Co's portfolio in Q2 2020, its #22 holding.
  • Stralem & Co first reported a position in Pfizer in Q2 2013 and has held it in 29 quarters since.
  • Stralem & Co's Pfizer position peaked at $117M in Q2 2013.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Stralem & Co's 13F filing for Q2 2020, filed 20 Jul 2020.